I have been invited by my surgery for a review with a clinical pharmacist to review and discuss my diabetics control, and this will be funded by AstraZeneca. Has any one else been invited and can advise what this may involve. For background, October 2023 my HbA1c was 57 mmol/mol, and increased Metformin 500mg twice a day, started a diet in January 2024 and have lost 3 stone my HbA1c has reduced to 47 and no longer taking Metformin. Currently managing via diet with another stone to lose, and I am not keen to start new medication. Thanks